The BioFire® FilmArray® Respiratory Panel EZ (RP EZ)

1 test. 14 respiratory pathogens.

The new BioFire RP EZ uses a molecular syndromic approach to accurately detect and identify a wide range of pathogens – not just Flu A and Flu B. As a healthcare provider, this means your patients can receive the right treatment the first time, potentially leading to higher patient satisfaction and lower costs. And as the name implies, it’s easy and can be performed right in your office or clinic.1

Nail It With One Swab.

Because a large number of pathogens cause respiratory infections, tests that only identify Flu A and B run the risk of missing the real culprit. Many rapid influenza diagnostic tests sacrifice accuracy for speed, with sensitivities ranging from 50-70%.2

The FilmArray RP EZ provides an accurate, comprehensive alternative to targeted influenza testing, and will detect a greater number of pathogens no matter the season or the time of year.3

REQUEST A DEMO

Respiratory Panel EZ

Sample Type: Nasopharyngeal swab

14 Targets in one test

14 TARGETS IN ONE TEST

The FilmArray RP EZ tests for a comprehensive set of 14 respiratory viral and bacterial pathogens. The FilmArray RP EZ is a CLIA-waived version of the CE marked, FDA-cleared FilmArray® Respiratory Panel (RP), and is designed to run on a single computer/instrument configuration (EZ Configuration) of the FilmArray® 2.0.

Product not available outside U.S.

RESPIRATORY PANEL EZ MENU

VIRUSES:

  • Adenovirus
  • Coronavirus
  • Human Metapneumovirus
  • Human Rhinovirus/Enterovirus
  • Influenza A
  • Influenza A/H1
  • Influenza A/H3
  • Influenza A/H1-2009
  • Influenza B
  • Parainfluenza Virus
  • Respiratory Syncytial Virus

BACTERIA:
BACTERIA:
BACTERIA:

  • Bordetella pertussis
  • Chlamydophila pneumoniae
  • Mycoplasma pneumoniae

Appropriate treatment relies on knowing, not guessing.

Among ambulatory care visits in the U.S., only 50% of antibiotic prescriptions for acute respiratory infections were estimated to be appropriate.4 In 2016, to combat the growing threat of antibiotic resistance, the President’s National Action Plan called for a goal of reducing antibiotics prescribed for acute respiratory conditions by 50% in 2020.5 The FilmArray RP EZ may help you increase patient satisfaction by aiding more accurate and timely diagnoses, while potentially reducing unnecessary antibiotic prescriptions.

Your place. Our test.

Traditionally, clinical care of respiratory tract infections is designed around syndromic disease management and centralized laboratory testing.6 Now laboratory testing is shifting to decentralized, near-patient settings, creating a simplified process with faster results.7 With the shift toward value-based care, you can do what is best for the patient while reducing untimely and expensive send-out tests.

REQUEST A DEMO

“I have extensive experience with the [FilmArray]. I truly believe that [it is] absolutely essential in my clinical practice. The information can assist in antibiotic stewardship… It is rapid and accurate.”

Ricardo Flores, MD, Director, Pediatric Critical Care Medicine at Marian Regional Medical Center

1CLIA Certificate of Waiver required to perform testing.
2http://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm
3Schreckenberger PC, McAdam AJ. J Clin Microbiol. 2015;53:3110-3115.
4Fleming-Dutra KE et al. JAMA. 2016;315(17):1864-1873
5Pew Charitable Trust Report. Antibiotic Use in Outpatient Settings. 2016
6Jani IV et al. NEJM 2013;368(24):2319-2324.
7Abel et al. Expert Rev. Mol. Diagn. 2015;15(7):853-855.